The most common side effects of Depo-Provera include headache, nausea, and abdominal pain. These side effects usually go away as your body adjusts to the medication. However, if you experience any side effects that last longer than a few days, stop using Depo-Provera and seek medical attention right away. Talk to your doctor to find out if this medication is right for you. Your health care professional will be able to provide you with the most accurate diagnosis and treatment plan.
If you experience any side effects that last more than a few days, talk to your health care professional right away.
If you have been trying to become pregnant for several months or have gone through a period for the past month, it is important to talk to your healthcare professional first. Birth control pills may make the most sense for you, but there are certain birth control pills that have worked for you. If you get a prescription for Depo-Provera and you are unsure of its effectiveness or if this medication might be right for you, it is important to talk to your healthcare professional about your options.
If you are having trouble getting pregnant while using Depo-Provera, there are many birth control pills that can be used to get pregnant. Depo-Provera can be used along with birth control pills, which are taken once a day. Depo-Provera can also be used to prevent pregnancy and to reduce the risk of having a baby if you get pregnant. If you are interested in using Depo-Provera for birth control, you should talk to your healthcare professional first. They can provide you with the most accurate diagnosis and treatment plan.
Side effect that has been reported with Depo-Provera is abdominal pain. It is important to note that abdominal pain, spotting or bleeding between periods, or other menstrual irregularities have not been directly reported with this medication. Other side effects that have been reported include headache, nausea, or breast tenderness. If you experience any of these symptoms, stop using Depo-Provera and contact your healthcare professional immediately.
Pharmacotherapy of the Depo-Provera (depri-provera-subcutaneous injection) is a depot injection of medroxyprogesterone acetate (Depo-Provera), an injectable contraceptive, that is administered by the methods of injection, vaginal injection, or intramuscular injection. The first phase of the Pregnancy, Lactation and Breastfeeding studies evaluated the effects of Depo-Provera on a group of women with a body mass index (BMI) ≥27 kg/m2. In phase 1, a total of 28 women, aged 40 to 70 years, completed the Pregnancy, Lactation, and Breastfeeding trials, and were assigned to receive the depot injection of medroxyprogesterone acetate (Depo-Provera) for five years. Each woman completed a 12-week period of follow-up, during which she completed the 12-week dose-response trial, and was followed up at 2, 4, 6, and 12 months. The primary endpoint of the Pregnancy, Lactation, and Breastfeeding studies was the number of days of pregnancy at 12 months of follow-up. At months 2, 4, 6, and 12, the number of days of pregnancy at 12 months of follow-up was significantly lower in the Depo-Provera group than in the control group (p <0.05) and significantly lower than in the placebo group (p <0.01). In the Depo-Provera-vaginal injection group, the number of days of pregnancy at 12 months of follow-up was significantly lower than the placebo group (p <0.05). At 2 and 4 months, there was a significantly greater number of days of pregnancy at 12 months of follow-up in the Depo-Provera group than in the placebo group and significantly greater days of pregnancy at 12 months of follow-up in the Depo-Provera-intramuscular injection group than in the placebo group (p <0.05). At 12 months, there was a significantly greater number of days of pregnancy at 12 months of follow-up in the Depo-Provera group than in the placebo group and significantly greater days of pregnancy at 12 months of follow-up in the Depo-Provera-vaginal injection group than in the placebo group (p <0.05).
There are no data available for women with a body mass index ≥27 kg/m2, who have not been diagnosed with diabetes mellitus or who are unable to use Depo-Provera, because these women have been assigned to use the depot injection of medroxyprogesterone acetate for five years and the number of days of pregnancy at 12 months of follow-up was significantly lower than that in the control group (p <0.05). In women who have not had diabetes, the number of days of pregnancy at 12 months of follow-up was significantly lower than that in the control group (p <0.01). In the Depo-Provera-intramuscular injection group, the number of days of pregnancy at 12 months of follow-up was significantly lower than the placebo group (p <0.01).
Pharmacological intervention should be based on the recommendations of the American College of Obstetricians and Gynecologists (ACOG) guidelines regarding the use of depot medroxyprogesterone acetate in women with severe or active diabetes mellitus or gestational diabetes mellitus. The American College of Obstetricians and Gynecologists has classified women with a body mass index of 28 kg/m2 as having diabetes mellitus or gestational diabetes mellitus. This study was an observational study. The study was approved by the Ethics Review Board of the Medical University of Vienna, Austria. All women gave written informed consent.
The study was performed in two phases. In the first phase, the study protocol was updated. The patient population included women with a body mass index of 28 kg/m2, who were diagnosed with diabetes mellitus, or gestational diabetes mellitus, who were treated with a combination of medications and insulin injections. The study was conducted in the absence of a commercial license and approval from the Ethics Committee for Research in Medicine at the Medical University of Vienna. In addition, all women gave written informed consent.
A: Successfully taking a hormone replacement device (e.g., a birth control device, injection device, or other drug) or taking a hormone replacement medication (e.g., birth control pills, patches, rings, etc.) requires a prescription from a health care provider. If you are not sure, you can schedule a consultation with one of our healthcare providers by calling our private healthcare service line at 1-800-222-1222.
A: The best time to take OBJECTION CHAMPUS is 30 minutes before anticipated sexual activity. It is important to remember that timing is always based on your body's needs and how you respond to the medication. For example, if you take an oral contraceptive, you might take a pill or ring a pill to feel more natural. It is also important to remember that each pill has its own unique set of instructions. Always follow your provider's recommendations.
A: While OBJECTION CHAMPUS is a generally safe medication, it is not suitable for everyone. It is important to consult a health care provider if you have liver disease, kidney disease, diabetes, an overactive thyroid, depression, bipolar disorder, nerve pain, or a history of cancer.
A: The effects of OBJECTION CHAMPUS can last up to 36 hours. However, it is important to note that this medication does not have a ceiling price. Your pharmacy will issue a prescription if it is necessary to spend some time with OBJECTION CHAMPUS.
A: Side effects of OBJECTION CHAMPUS can include headaches, dizziness, depression, and swelling of the ankles or feet. Talk to your provider if any of these side effects bother you.
A: While OBJECTION CHAMPUS is not recommended for daily use, it is recommended to use it without the direct supervision of a healthcare provider. Grapefruit juice should be used with caution, especially when taking medication that contains grapefruit products. Avoid consuming alcohol while taking OBJECTION CHAMPUS and for 4 hours after you start taking the medication.
A: If you experience severe side effects such as chest pain, shortness of breath, or weakness due to swelling, pain, or discomfort, contact your healthcare provider immediately. Your provider will weigh you to ensure that you are fully supportive of your well-being.
A: OBJECTION CHAMPUS is not recommended for use in children or animals. It is only used as prescribed and approved by your health care provider. If you have already been diagnosed with dementia, OBJECTION CHAMPUS may not be suitable for you if you are taking other medications, including prescription drugs.
A: OBJECTION CHAMPUS is not recommended for use with alcohol. Your provider will independently find out what can be done for you and adjust the dosage if needed.
A: You should not use OBJECTION CHAMPUS if you have ever had an allergic reaction to any of its ingredients. Your provider will need to determine if OBJECTION CHAMPus is suitable for you and if so, what can be done to stop it from causing any side effects.
The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser.For the best experience on our site, be sure to turn on Javascript in your browser.
$9.99
Quick OverviewYour local pharmacy offers this treatment.
* We can attach Hormone Replacement Therapy (HRT) to the injection to improve its effectiveness. The HRT may decrease your ovulation (spotting) between days 3-7 of the cycle.
* Once every 3 months or until your cycle stops.
* Please note that HRT is not recommended for use by more than 3 months of age due to potential side effects.
* If you experience any side effects or have concerns about your treatment, please consult your doctor. We’re a short-term treatment and not a long-term solution.
* Please note that we’re a prescription-only provider and may need to monitor you for certain side effects (HRT is only prescribed if you have a medical condition).
* If your condition does not improve after 3 months of receiving Clomid, we’ll change your treatment and send you back to your local pharmacy for repeat use.
Remember that this information is for general informational and educational purposes only and not intended to replace medical advice, all treatments, or diagnosis.
based on 2023 Medicare information| Drug Class | Clomiphene Citrate (Clomid) |
|---|---|
| Brand/Trade Name | Hormone Replacement Therapy |
| Generic/Brand | |
| Missed Dose? | Notify your doctor |
| Fraudulent Use of Formulations | Use inmedikare, fonselt |
| Yes/No Information | No |
Stade de France Pharmacy